Yellow Fever in Non-Human Primates: A Veterinary Guide from a One Health Perspective DOI Creative Commons
Remco A. Nederlof, Tommaso Virgilio,

Hendrickus J. J. Stemkens

et al.

Veterinary Sciences, Journal Year: 2025, Volume and Issue: 12(4), P. 339 - 339

Published: April 6, 2025

Yellow fever (YF) causes severe morbidity and mortality in Africa South America. It is an arthropod-borne viral disease endemic to tropical regions of virus (YFV) transmitted by mosquitoes frequently affects both non-human primates (NHPs) humans. Neotropical (NTPs) are generally more severely afflicted YFV than African primates. Asian appear not be susceptible this disease. Susceptibility varies among NTP species: asymptomatic infections described some species, whereas epizootic events others. The genus Alouatta (howler monkeys) considered the most NTPs. Epizootic resulting death thousands NTPs have been recorded recent history. As a result, poses threat survival species. In cases, found dead without showing prior clinical signs. cases where signs observed, they mostly non-specific. Due their high susceptibility, used as epidemiological predictors for human YF outbreaks. infection may diagnosed means isolation, reverse transcription polymerase chain reaction, serology, histopathology, or immunohistochemistry. Animals that survive develop neutralizing antibodies YFV. Currently, no specific treatment available. Sustained control strategies must rely on surveillance accurate diagnostics allow early detection outbreaks rapid implementation measures. Prophylaxis should based One Health perspective recognizes intricate interplay between health, primate environment. Vaccines available, with 17DD vaccine effectively preventing However, mitigation continue vector control, preferably using eco-friendly methods. Climate change activities, impact local ecology, assumed increase risk transmission next decades.

Language: Английский

Yellow Fever in Non-Human Primates: A Veterinary Guide from a One Health Perspective DOI Creative Commons
Remco A. Nederlof, Tommaso Virgilio,

Hendrickus J. J. Stemkens

et al.

Veterinary Sciences, Journal Year: 2025, Volume and Issue: 12(4), P. 339 - 339

Published: April 6, 2025

Yellow fever (YF) causes severe morbidity and mortality in Africa South America. It is an arthropod-borne viral disease endemic to tropical regions of virus (YFV) transmitted by mosquitoes frequently affects both non-human primates (NHPs) humans. Neotropical (NTPs) are generally more severely afflicted YFV than African primates. Asian appear not be susceptible this disease. Susceptibility varies among NTP species: asymptomatic infections described some species, whereas epizootic events others. The genus Alouatta (howler monkeys) considered the most NTPs. Epizootic resulting death thousands NTPs have been recorded recent history. As a result, poses threat survival species. In cases, found dead without showing prior clinical signs. cases where signs observed, they mostly non-specific. Due their high susceptibility, used as epidemiological predictors for human YF outbreaks. infection may diagnosed means isolation, reverse transcription polymerase chain reaction, serology, histopathology, or immunohistochemistry. Animals that survive develop neutralizing antibodies YFV. Currently, no specific treatment available. Sustained control strategies must rely on surveillance accurate diagnostics allow early detection outbreaks rapid implementation measures. Prophylaxis should based One Health perspective recognizes intricate interplay between health, primate environment. Vaccines available, with 17DD vaccine effectively preventing However, mitigation continue vector control, preferably using eco-friendly methods. Climate change activities, impact local ecology, assumed increase risk transmission next decades.

Language: Английский

Citations

0